All Posts By

Redpin Therapeutics

New Paper in Science Reports Discovery of Ultrapotent Chemogenetic Approach that Forms Scientific Foundation for Redpin Therapeutics’ Technology

By | Press Release
Engineered receptors and ultrapotent, FDA-approved agonists enable clinical applications of chemogenetics Novel ion channel-based platform allows targeted cell activation or silencing controlled by low doses of the anti-smoking drug varenicline Redpin leveraging platform to advance pipeline of targeted cell therapies...
Read More